கேன்சினோ உயிர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கேன்சினோ உயிர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கேன்சினோ உயிர் Today - Breaking & Trending Today
COVID-19 vaccination certificate mandatory for domestic air travel: NCOC geo.tv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geo.tv Daily Mail and Mail on Sunday newspapers.
Pakistan earns $10m from phase 3 trials of CanSino July 12, 2021 ISLAMABAD: The National Institute of Health (NIH) Executive Director Major General Aamer Ikram has revealed that Pakistan earned a whopping $10m from conducting phase 3 trials of the Chinese vaccine CanSino. The NIH has played an important role in the efforts to check dissemination of coronavirus under the General who was speaking at a function where he disclosed that many countries wanted to hold their phase 3 trials in Pakistan. “These experiments can bring millions of dollars into Pakistan,” he said. Major General Aamer Ikram said that Pakistan had also started co-manufacturing the single-dose Adenovirus-vectored Covid-19 vaccine with CanSino Bio at the NIH Islamabad, and claimed that within a year, they were hopeful of earning around $30 million through the joint manufacturing of the vaccine in the country. “And this successful venture has opened doors of numerous more such opportunities f ....
July 11, 2021 Pakistan has earned $10 million by conducting first-ever Phase-III clinical trials for the single-dose Chinese Covid-19 vaccine CanSino Bio at five leading public and private health facilities in the country, and now the National Institute of Health (NIH) is going to earn 30 million dollars within a year by co-manufacturing the same vaccine after technology transfer from China, officials said on Saturday. “Phase-III clinical trials of the CanSino Biologics single-dose Covid-19 were the first-ever such trials conducted in Pakistan and we earned $10 million by conducting these trials at five centres in Karachi, Lahore and Islamabad. Now we are being approached by companies from the UK, Korea and Japan, as well as from China for conducting Phase-III clinical trials of several more vaccines, which can earn us huge revenue and foreign exchange,” said Major General Aamer Ikram, executive director of the National Institute of Health Islamabad, at a health confe ....
Pakistan earned $10mn from CanSino phase 3 trials: NIH By Maj Gen Aamer Ikram speaks at an event in Karachi. Photo: Geo News Many countries want to conduct phase 3 trials of their vaccines in Pakistan, says NIH head. Pakistan can earn millions of dollars from these trials, says NIH. Pakistan reported highest COVID positivity ratio since May 30 today. KARACHI: Pakistan earned a whopping $10mn from conducting phase 3 trials of the Chinese vaccine CanSino, revealed Maj Gen Aamer Ikram. Maj Gen Ikram, who is the head of the National Institute of Health (NIH) was speaking at a function in the city where he disclosed that many countries wanted to hold their phase 3 trials in Pakistan. ....